The new year brought a slew of new faces in the pharma and biotech world, especially in the top jobs, with a number of CEO ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

In today’s Pharmaceutical Executive Daily, Hims & Hers withdraws access to its compounded semaglutide pill following a controversy filled launch, next-generation trial designs increasingly integrate ...

The biotech is set to release its fourth-quarter and full-year 2025 financial results on Thursday, Feb. 12. Will the stock dip again after its earnings, or should investors consider buying Vertex's ...

WENZHOU, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- As the global pharmaceutical and healthcare ...

The third quarter was a pivotal period for both the biotech and pharmaceutical sectors, with regulatory developments and an increase in business deals shaping the landscape for the industries. Public ...

A key insight from the whitepaper is the increasing divergence in verification expectations between regions. While the EU ...

As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's ...

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) ('Ascentage Pharma” or the 'Company, a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, ...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the most promising future stocks to buy now. Piper Sandler revised the ...

DUBAI, 9th February, 2026 (WAM) -- Saeed bin Mubarak Al Hajeri, Minister of State and Chairman of the Board of Directors of the Emirates Drug Establishment, today officially launched the Emirates Drug ...

The Philippine pharmaceutical industry has attracted more than P18 billion in investments within Philippine Economic Zone ...